Poly Medicure, a leading Indian manufacturer and exporter of medical devices, is planning to invest in newer technologies and is enhancing its R&D capabilities to deliver high quality medical devices at affordable prices.
The company is also planning to collaborate and work closely with all stakeholders such as the government, private sector as well as the medical research fraternity to develop new products.
"Our business would include releasing new products in the field of renal, respiratory care and diagnostics business. We are also breaking the old boundaries and redefining our model which is clinical focused as even Medtech players need to be more focused on value-based and patient-focused care. To achieve this, we will ensure that user-centered design should begin early and continue throughout device development. The priorities of the clinical users were identified, as well as a number of factors that would act to the safe and effective adoption of the device," stated Himanshu Baid, managing director, Poly Medicure Ltd.
The company will be focusing on the growth prospects in the fast-growing segments, while maintaining position in the slow-growing segments.
"As the COVID-19 pandemic disrupts nearly every aspect of life, Polymed has turned to digital technology and analytics to help us prepare for new ways of empowering the team and serving customers once we reach the other side. We had initiated internal training programmes to upskill our workforce with clinical and product knowledge. This situation also gave us an opportunity to engage digitally with the healthcare community by means of webinars bringing veterans from the industry. These virtual programs enabled us to build online learning events aimed at imparting knowledge and skills to different set of healthcare professionals,” Baid said.
“We have already started investing in digital transformation and have found it easier to cope with global lockdowns that have forced entire workforces into telecommuting. It has helped us rival with rapid supply chain changes and workplace together with unpredictable business needs that the pandemic has raised,” he added.
With focus on innovation, safety & quality, the company exports its products to more than 110 countries. The company has 9 ultra-modern manufacturing facilities out of which 6 facilities are in India and one each in Italy, Egypt (Joint Venture) and China. Polymed owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team.
|